AdreView (Medi-Physics Inc.)
Welcome to the PulseAid listing for the AdreView drug offered from Medi-Physics Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Medi-Physics Inc. |
NON-PROPRIETARY NAME: | Iobenguane I-123 |
SUBSTANCE NAME: | IOBENGUANE I-123 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-09-19 |
END MARKETING DATE: | 0000-00-00 |
AdreView HUMAN PRESCRIPTION DRUG Details:
Item Description | AdreView from Medi-Physics Inc. |
LABELER NAME: | Medi-Physics Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2(mCi/mL) |
START MARKETING DATE: | 2008-09-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17156-235_bf3ce582-7976-4708-be4d-4fb30c0336dd |
PRODUCT NDC: | 17156-235 |
APPLICATION NUMBER: | NDA022290 |
Other IOBENGUANE I-123 Pharmaceutical Manufacturers / Labelers: